Arcadia Q2 net loss $4.5M on $4.5M credit loss; Zola revenue up 24%

Arcadia Biosciences, Inc.

2025-Q2 EPS reported -$1.36 revenue$2,655,000

Total revenue $1.455M (+11% YoY); Zola coconut water sales grew 24% to $1.455M.
Net loss attributable to common $4.458M ($3.26/share) vs net income $1.061M ($0.78/share) in Q2 2024.
Recorded $4.5M credit loss on Above Food note receivable; received 2.7M shares of ABVE stock.
Eliminated $1M contingent liability via Bioseed India license termination; total YTD eliminated $2M.
Gross margins exceeded 30% for tenth consecutive quarter; SG&A fell 21% to $2.123M.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.